Shawn Kwatra, MD, presented new data on nemolizumab demonstrating its long-term and increasing efficacy on skin lesions and improved itch in prurigo nodularis through week 52 in the OLYMPIA long-term extension (LITE) study. #AAD2024 dermatologytimes.com/view/late-brea…

👏 #AAD2024 was the largest dermatology conference in the history of the world! Had a great time speaking on topics from sharing my playbook for chronic itch to jak inhibitors in dermatology and the OX40 ligand pathway & beyond. Can’t wait for next year!

Excited to share our JAMA Dermatology viewpoint bitly.ws/3fSDp examining immunotherapy in localized melanoma. Big congrats to Hannah Rashdan in my lab for leading the piece, which was also a hot topic @ the most recent Melanoma Research meeting! Thx to Ade Adamson, MD MPP for his collab.

📌 Late-breaking results for #nemolizumab were presented by Dr. Shawn Kwatra at #AAD2024: 🔑Nemolizumab improved #prurigonodularis in up to 69% of patients by week 52. 🔑Up to 62% of patients with #atopicdermatits achieved IGA 0 or 1 by week 48. bit.ly/3TBZevi

Interventional itch therapeutics is the future! We are reporting the invention of a new procedure for treating patients with scalp pruritus and dysesthesias via bedside greater occipital nerve blocks with bupvicaine - bitly.ws/3icBI #itch #dermtwitter

Excited to kick off at SID with a talk on the OX40 Ligand Pathway. Come join some of our lab’s talks #eczema #prurigo #SID2024Dallas Jaya Manjunath

Had a great weekend speaking at the 2024 Congress of Clinical Dermatology in Amelia Island. Great conference and enjoyed sharing the latest advances in itch diagnosis and therapeutics.

So excited to announce Kristin Khan, MD as the first new dermatology recruit under my tenure University of Maryland School of Medicine. Dr. Khan has specialty expertise in acne, rosacea, & seborrheic dermatitis and will serve our educational mission as APD & Director of Medical Student Education.

University of Maryland School of Medicine dermatology chair Dr. Shawn Kwatra published important new finding in JAMA Dermatology on promising new treatment for intense itching condition, prurigo nodularis, which is understudied and disproportionately affects patients of color. tinyurl.com/y7kt2uyh

Join me and my fellow program chairs at the 71st Annual Montagana Symposium, titled “Skin of Color Dermatology: The Interaction of Science & Society” as we bring together basic/translational researchers with social scientists to present the latest advancements in skin biology!

I am thrilled to announce Dr. Aisha Mumtaz will be joining the Department of Dermatology University of Maryland School of Medicine! Dr. Mumtaz joins us from Mount Sinai Dermatology Mount Sinai Dermatology and will direct a first of its kind oculocutaneous diseases specialty clinic #dermtwitter

Had a great 4th of July in 🇬🇧Dermatology Healthcare Professionals at the 104th Annual Meeting of the British Association of Dermatologists. Also enjoyed visiting Leeds Hospital NHS England to give grand rounds on chronic itch from atopic dermatitis to prurigo & beyond #BAD2024 #dermtwitter

Single-cell RNA sequencing reveals dysregulated POSTN+WNT5A+ fibroblast subclusters in prurigo nodularis doi.org/10.1016/j.jid.… #JIDJournal #dermscience #dermtwitter Dr. Shawn Kwatra

Excited to share our report in JAAD Journals on a unique phenotype of chronic itch developing following immune stimulus exposure, be it viral flare, vaccination, or drug exposure, w/ a mechanistic role for elevated circulating blood type 2 inflammation rb.gy/d9n244

Happy to share my lab’s real-world precision medicine study on dupilumab treatment reversing circulating blood inflammation and mediators of fibrosis in prurigo nodularis patients rb.gy/yktkd7 #itch #dermtwitter

The itch world woke up on 🔥 this morning with the FDA approval of #nemolizumab for #prurigo nodularis (PN). It was an honor to serve as the lead investigator of the Olympia program resulting in a breakthrough therapy for #PN patients tinyurl.com/tjbmymh3 #dermtwitter #itch

Dr. Shawn Kwatra led a compelling study that found low levels of metabolite biomarkers in the blood plasma of patients w/ chronic pruritus of unknown origin (CPUO). Could pave the way for new targeted treatments to help relieve excruciating itch symptoms. ow.ly/Ia0z50SXVjI

Thank you Baltimore magazine for featuring me as a “Man on the Move” & highlighting the incredible trajectory of the Department of Dermatology University of Maryland School of Medicine University of Maryland Medical Center as we rapidly grow our regional, national, and international leadership #dermtwitter bitly.cx/mJiq

Had a great time speaking Skin of Color Update this weekend about #itch & seborrheic dermatitis, including recent new FDA approvals that are changing the management landscape #dermtwitter

Thank you Medscape for covering my talk over the weekend Skin of Color Update tinyurl.com/3mdy6sv7 highlighting the incredible progress being made for skin of color patients with seborrheic dermatitis, one of dermatology’s long forgotten diseases #dermtwitter